424 related articles for article (PubMed ID: 29614184)
21. The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention.
Wine O; McNeil D; Kromm SK; Foss K; Caine V; Clarke D; Day N; Johnson DW; Rittenbach K; Wood S; Hicks M
BMC Health Serv Res; 2023 May; 23(1):448. PubMed ID: 37149626
[TBL] [Abstract][Full Text] [Related]
22. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.
Hall ES; Wexelblatt SL; Crowley M; Grow JL; Jasin LR; Klebanoff MA; McClead RE; Meinzen-Derr J; Mohan VK; Stein H; Walsh MC;
Pediatrics; 2014 Aug; 134(2):e527-34. PubMed ID: 25070317
[TBL] [Abstract][Full Text] [Related]
23. Neonatal opioid withdrawal syndrome.
Sutter MB; Leeman L; Hsi A
Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
[TBL] [Abstract][Full Text] [Related]
24. Neonatal abstinence syndrome management in California birth hospitals: results of a statewide survey.
Clemans-Cope L; Holla N; Lee HC; Cong AS; Castro R; Chyi L; Huang A; Taylor KJ; Kenney GM
J Perinatol; 2020 Mar; 40(3):463-472. PubMed ID: 31911649
[TBL] [Abstract][Full Text] [Related]
25. A Hospital-Level Intervention to Improve Outcomes of Opioid Exposed Newborns.
Cree M; Jairath P; May O
J Pediatr Nurs; 2019; 48():77-81. PubMed ID: 31352111
[TBL] [Abstract][Full Text] [Related]
26. Rooming-in for Infants at Risk of Neonatal Abstinence Syndrome.
McKnight S; Coo H; Davies G; Holmes B; Newman A; Newton L; Dow K
Am J Perinatol; 2016 Apr; 33(5):495-501. PubMed ID: 26588259
[TBL] [Abstract][Full Text] [Related]
27. Outcome reporting in neonates experiencing withdrawal following opioid exposure in pregnancy: a systematic review.
Shan F; MacVicar S; Allegaert K; Offringa M; Jansson LM; Simpson S; Moulsdale W; Kelly LE
Trials; 2020 Mar; 21(1):262. PubMed ID: 32164782
[TBL] [Abstract][Full Text] [Related]
28. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.
Kraft WK; Adeniyi-Jones SC; Chervoneva I; Greenspan JS; Abatemarco D; Kaltenbach K; Ehrlich ME
N Engl J Med; 2017 Jun; 376(24):2341-2348. PubMed ID: 28468518
[TBL] [Abstract][Full Text] [Related]
29. Breastfeeding among Mothers on Opioid Maintenance Treatment: A Literature Review.
Tsai LC; Doan TJ
J Hum Lact; 2016 Aug; 32(3):521-9. PubMed ID: 27053175
[TBL] [Abstract][Full Text] [Related]
30. Opioid Neonatal Abstinence Syndrome: An Overview.
Wexelblatt SL; McAllister JM; Nathan AT; Hall ES
Clin Pharmacol Ther; 2018 Jun; 103(6):979-981. PubMed ID: 29285767
[TBL] [Abstract][Full Text] [Related]
31. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
Velez ML; Jordan C; Jansson LM
Neurotoxicol Teratol; 2021; 88():107032. PubMed ID: 34600100
[TBL] [Abstract][Full Text] [Related]
32. Nonpharmacologic Management of Neonatal Abstinence Syndrome: An Integrative Review.
Edwards L; Brown LF
Neonatal Netw; 2016; 35(5):305-13. PubMed ID: 27636695
[TBL] [Abstract][Full Text] [Related]
33. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
[TBL] [Abstract][Full Text] [Related]
35. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
O'Connor AB; Collett A; Alto WA; O'Brien LM
J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
[TBL] [Abstract][Full Text] [Related]
36. Comparative effectiveness of opioid replacement agents for neonatal opioid withdrawal syndrome: a systematic review and meta-analysis.
Lee JJ; Chen J; Eisler L; Li G; Davis JM; Sun LS
J Perinatol; 2019 Nov; 39(11):1535-1545. PubMed ID: 31316147
[TBL] [Abstract][Full Text] [Related]
37. Neonatal abstinence syndrome.
Grossman M; Berkwitt A
Semin Perinatol; 2019 Apr; 43(3):173-186. PubMed ID: 30773241
[TBL] [Abstract][Full Text] [Related]
38. Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence Syndrome.
Czynski AJ; Davis JM; Dansereau LM; Engelhardt B; Marro P; Bogen DL; Hudak ML; Shenberger J; Wachman EM; Oliveira EL; Lester BM
J Pediatr; 2020 Apr; 219():146-151.e1. PubMed ID: 31987653
[TBL] [Abstract][Full Text] [Related]
39. Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants.
Devlin LA; Young LW; Kraft WK; Wachman EM; Czynski A; Merhar SL; Winhusen T; Jones HE; Poindexter BB; Wakschlag LS; Salisbury AL; Matthews AG; Davis JM
J Perinatol; 2022 Mar; 42(3):300-306. PubMed ID: 34556799
[TBL] [Abstract][Full Text] [Related]
40. Neonatal Abstinence Syndrome.
Khan L
Pediatr Ann; 2020 Jan; 49(1):e3-e7. PubMed ID: 31930416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
